R&D Future of generative AI in pharma Talk of implementing automation and AI to enhance human capacity is dominating conversations.
News BenevolentAI, AstraZeneca AI-based drug discovery collaborat... BenevolentAI has discovered a second novel target for idiopathic pulmonary fibrosis (IPF), which AstraZeneca has added to its drug development portfolio, resulting in a milestone payment to the Lon
News Digital health companies enabling R&D topped 2021 US investm... According to Rock Health's annual digital health funding report, US-ba
News Former Seagen CEO Siegall pops up at new biotech Siegall resigned from Seagen last year amid claims of domestic abuse, though was not charged.
R&D Sponsored An inside guide to unlocking clinical research in the UK An inside guide to unlocking clinical research in the UK
